| No. |
Date |
Time |
Seminar Title |
Register |
| Keynote / Special Seminar |
| 6K-01 |
9 April (Wed.) |
09:15
|
10:15 |
Regulatory effort to eliminate Drug-Lag/Drug-Loss problem and to ensure stable supply of pharmaceuticals
※Opening Ceremony will be held from 9:15am
Mr. Daisuke Sato
Section Chief
Pharmaceutical Evaluation Division
Pharmaceutical Safety Bureau
Ministry of Health, Labour and Welfare
|
|
| 6K-03 |
9 April (Wed.) |
13:00
|
14:00 |
Japan's universal health care system and pharmaceutical industry in Japan
Mr. Toshihiko Miyajima
Director General
The Federation of Pharmaceutical Manufacturer's Association of Japan
|
|
| 6K-09 |
10 April (Thu.) |
13:30
|
15:30 |
ーJPTA Symposiumー
Recent Situation and Challenges in stable supply of Active Pharmaceutical Ingredients
Evaluation and Management of Nitrosamines
Dr. Masahiro Uchino, Chief Reviewer, Office of Generic Drugs, PMDA
Issues for streamlining the GMP Conformity Assessment System
Mr. Koki Akazawa, Deputy Division Manager,
Office of Manufacturing Quality for Drugs, Division of Inspection for Drugs Ⅱ, PMDA
The revision of the European Pharma Package *broadcasting
Ms. Marieke van Dalen, MARA
Practical issues in promoting a stable supply of imported APIs from JPTA's perspective
Mr. Hiroshi Nakamura, Chairman, Legal Affairs Committee, JPTA
Panel Discussion
Moderator
Mr. Ichiro Fujikawa, Chairperson, JPTA
Panelists
Dr. Masahiro Uchino, Chief Reviewer, Office of Generic Drugs, PMDA
Mr. Koki Akazawa, Deputy Division Manager,
Office of Manufacturing Quality for Drugs, Division of Inspection for Drugs Ⅱ, PMDA
Mr. Hiroshi Nakamura, Chairman, Legal Affairs Committee, JPTA
Mr. Tadashi Asakoshi, Legal Affairs Committee, JPTA
Mr. Toshiyuki Harashima, Legal Affairs Committee, JPTA
|
|
| 6K-10 |
10 April (Thu.) |
15:45
|
16:30 |
Trends Shaping Global Biopharma R&D In 2024
Mr. Ian Haydock
Editor-In-Chief, APAC
Insights
Citeline (a Norstella company)
|
|
| 6K-12 |
11 April (Fri.) |
09:30
|
10:30 |
Drug Discovery and Manufacturing Innovation of Chugai: Strategy and Vision
Dr. Osamu Okuda
Representative Director, President & CEO
Chugai Pharmaceutical Co., Ltd.
|
|
| 6K-16 |
11 April (Fri.) |
16:00
|
16:45 |
Government Initiatives for Ensuring Thorough Manufacturing and Quality Control of Pharmaceuticals
Mr. Go Yamamoto
Director Office of inspection and Guidance, Director for Counter Narcotics
Compliance and Narcotics Division, Pharmaceutical Safety Bureau
Ministry of Health, Labour and Welfare
|
|
| Process Chemistry Seminar |
| 6A-14 |
11 April (Fri.) |
11:00
|
11:45 |
※Updated Mar 7
Developing a safe and scalable processes from gram scale to multi tons production, challenges and mitigations during the scaleup
Dr. Raghavendar Rao
Head of R＆T
Research and Technology Center
Hikal Limited
|
|
| Biopharma Seminar |
| Biopharma Seminar【Seminar Room 5A（East Hall5）】 |
| 5A-02 |
9 April (Wed.) |
11:30
|
12:15 |
The strategy and positioning in Japan of global company specializing in antibody biopharma
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
Mr. HoUng Kim
President and Representative Director,
CELLTRION HEALTHCARE Japan K.K
Cooperate Executive Vice president
Head of JAL (Japan, Asia, Laten America) division,
CELLTRION INC.
|
|
| Bio Pharma Seminar【Seminar Room C8（608, Conference Tower）】 |
| C8-07 |
10 April (Thu.) |
10:15
|
11:30 |
TIDES collaboration project ～International conference on diffusion & peptide therapeutics in CPHI Japan～
1. Advances in Oligonucleotide Therapeutics
2. Bispecific Antibodies for Oncology and Autoimmune Diseases
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
Muthiah (Mano) Manoharan, Ph.D.
Senior Vice President of Drug Innovation and Distinguished Research Scientist
Alnylam Pharmaceuticals
John Desjarlais, Ph.D.
Chief Scientific Officer,
Xencor, USA
|
Full |
| DDS/Packaging/Preparation Development Seminar |
| C6-19 |
11 April (Fri.) |
14:40
|
15:10 |
Drug-Device Combination Products including Biocon’s peptide technology
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
Mr. Manoj Kumar Pananchukunnath
Chief Scientific Officer
Research and Development
Biocon Ltd.
|
|
| CDMO Seminar |
| C7-16 |
11 April (Fri.) |
11:45
|
12:30 |
※Updated Mar10
How strong Japan & India partnerships accelerate the manufacturing of novel APIs, biologics, and peptides.
Mr. Akhil Ravi
Chief Executive Officer (CEO)
Aurigene Pharmaceutical Services Limited
|
|
| Private Seminar |
| Private Seminar【Seminar Room C8（608, Conference Tower）】 |
| C8-03 |
9 April (Wed.) |
13:00
|
14:45 |
※Updated Mar 6
The seminar has been canceled due to the speaker's circumstances.
Sustainability in Healthcare and Pharm
REVA PHARMA
Founder & CEO
Managing Department
Dr.Gurpreet Singh Sandhu
|
|
| Private Seminar【Seminar Room C1（102, Conference Tower）】 |
| C1-10 |
10 April (Thu.) |
11:00
|
12:30 |
※Updated Mar 5
Navigating India's Healthcare Landscape: Unlocking Opportunities and Breaking Market Barriers
Opening Remarks
Mr.Taisuke Hashimoto
Director, Healthcare Industries Division,
Commerce and Service Industry Policy Group,
Ministry of Economy, Trade and Industry (METI)
Welcome Address
Mr. Kenji Shibuya, MD
Chief Executive Officer
Medical Excellence JAPAN (MEJ)
Welcome Address
Dr.Manami Uechi
Director, Healthcare Services Economic Research Institute for ASEAN and East Asia (ERIA)
Keynote Speech
H.E. Mr. Sibi George
Ambassador of India to Japan
Embassy of India, Tokyo
Guest Lecture Session
“Overview of the Uttar Pradesh Medical Device Park (YEIDA)"
Dr. G.N. Singh
Chief Advisor to the Chief Minister
Government of Uttar Pradesh, India
“Unlocking India's Healthcare Potential: Opportunities and Strategic Partnerships”
Mr. Dilip Jose
Co-Chair, CII Health Care Council, MD & CEO
CII Health Care Council, Manipal Health Enterprises Pvt. Ltd.
“Possibilities for Collaboration and Differences in Business Practices and Culture between Japan and India"
Mr. Durgesh Sharma
Managing Director
CBC Corporation (India) Private Limited
"Challenges and Strategies for Overcoming Business Barriers in India"
Tomonaga Teshima & Saurabh Chawla
Co-Founder and CEO
OkayGo, India
Panel Discussion and Q&A
Empowering Healthcare Partnerships: Harnessing India's Networks and Opportunities to Drive Japanese Innovation
Moderator:
Mr. Yasuhiro Sensho, CEO SENSHO-GUMI Co., Ltd.
Panelist:
Mr.Taisuke Hashimoto (Ministry of Economy, Trade and Industry (METI))
Dr. Kenji Shibuya (Medical Excellence JAPAN)
Mr. Durgesh Sharma (CBC Corporation)
Mr. Tomonaga Tejima (Okaygo)
Mr. Saurav Chawla (Okaygo)
|
|
| Pharma IT Seminar |
| Pharma IT Seminar【4A】 |
| 4A-03 |
9 April (Wed.) |
12:30
|
13:15 |
IQVIA Japan Pharma Market Insights: Trends in Pharmaceutical Development and Commercialization
Mr. Alan Thomas
Senior Director
Japan Though Leadership
IQVIA Solutions Japan
|
|
| Phama IT Seminar【4C】 |
| 4C-10 |
10 April (Thu.) |
11:20
|
11:50 |
Introducing a New Platform for Drug Discovery Researchers
Mr. Adam Sanford
Director of the Life Sciences Division
CAS
|
|
| Supply Chain Seminar |
| Supply Chain Seminar【Seminar Room C7】 |
| C7-04 |
9 April (Wed.) |
13:30
|
14:30 |
Beyond the Numbers: Japan's Strategic Position in Global API Procurement
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
Mr. KAZUYUKI SAWADA
CEO
SUSUMIRU Consulting Co.,Ltd.
Former Manager,
Purchasing Department,
Sawai Pharmaceutical Co.,Ltd.
|
|
| Supply Chain Seminar【C5】 |
| C5-16 |
11 April (Fri.) |
11:45
|
12:30 |
Building an effective supply chain system tied up with CDMO
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
Mr. Tadao Takano
CEO / President of Bushu Pharmaceuticals Ltd.
|
|
| 11th FPMAJ International Seminar（Indonesia） |
| C7-05 |
9 April (Wed.) |
15:00
|
17:00 |
11th FPMAJ International Seminar（Indonesia）
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
|
|
| Sustainability Seminar |
| C8-04 |
9 April (Wed.) |
15:30
|
16:15 |
※Updated Mar 13 This seminar has been cancelled due to the speaker's circumstances.
Working together to create sustainable supply chains in pharma industry by The Pharmaceutical Supply Chain Initiative (PSCI)
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
|
|
| China Seminar |
| 6C-15 |
11 April (Fri.) |
11:00
|
11:45 |
Unlocking New Opportunities in API Procurement：
Building relationships with leading manufacturers, particularly in India, China and other countries
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
Mr. KAZUYUKI SAWADA
CEO
SUSUMIRU Consulting Co.,Ltd.
Former Manager
Purchasing Department
Sawai Pharmaceutical Co.,Ltd.
|
|
| 6C-16 |
11 April (Fri.) |
13:00
|
13:30 |
Enhancing Client Partnerships: Success Stories in Small Molecule CDMO Collaborations
*Japanese-English AI real-time translation subtitles available.
Attendees must provide their own smartphones and earphones.
Mr. Xing JIN
Director of BD
PharmaBlock Sciences (Nanjing), Inc.
|
|
